• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Spark Therapeutics Appoints CTO

    Cryoport Launches ESG Program

    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail

    Thermo Fisher Scientific Completes Mesa Biotech Acquisition

    Ashfield Engage, Popit Form Digital Monitoring Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Solid Dose Market Trends

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    C2 Pharma Completes Multiple Regulatory Filings

    Bormioli Opens New Glass Research Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Ashfield Engage, Popit Form Digital Monitoring Collaboration

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    test company saurabh

    Emergent BioSolutions

    Baxter BioPharma Solutions

    Adare Pharma Solutions

    PCI Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Syngene

    Adare Pharma Solutions

    Alcami

    test company saurabh
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Leveraging Deep Learning in Drug Research

    Dr. Christopher Bouton of Vyasa Analytics discusses the company’s deep learning Cortex and how it’s addressing R&D challenges

    Leveraging Deep Learning in Drug Research
    Related CONTENT
    • Legacy Pharma Solutions
    • PCI Pharma Services
    • Catalent Pharma Solutions
    • Regis Custom Pharma
    • Adare Pharma Solutions
    Kristin Brooks, Contract Pharma04.01.19
    Research has found that the costs of bringing on a new drug costs pharmaceutical companies an average of $2 billion, with the main culprits for high costs being high attrition rates and various other costs related to R&D. Vyasa’s Neural Concept Recognition technology, Cortex, aims to help pharma professionals cut through the massive amounts of data needed to begin identifying new chemical compounds during drug R&D. As a result, professionals can utilize data already available to them to identify previously hidden combinations, helping to cut costs and save time.
     
    Dr. Christopher Bouton, chief executive officer of Vyasa Analytics, discusses the company’s deep learning Cortex and how it’s addressing R&D challenges.  –KB
     
    Contract Pharma: What are the current obstacles drug developers look to overcome leveraging data?
     
    Christopher Bouton: The drug development process is a fundamentally data-driven activity. As a result, there are numerous elements in the process which involve the generation of large amounts of data of numerous types – including text, image, small compound and quantitative content. The challenge with all of this data, as we found during the “Big Data” phase, is it is not useful just for the sake of having a lot of data. Rather, the challenge is finding more effective ways of deriving insights from the vast troves of data that organizations now have access to. 
     
    In particular, having better tools for identifying unexpected patterns in the data which may lead to an “ah-ha” moment for a scientist would be a game-changing value driver. It just so happens that novel deep learning (i.e. AI) technologies are exceptionally good at this type of robust pattern recognition in data sources without the need for a priori rule set definitions. 
     
    Once we train a deep learning/AI agent on what to look for in data, it can climb into large data sources and sift through that content on a scale and with a speed that is simply not possible for humans in order to identify interesting trends, patterns and insights in the content.
     
    Contract Pharma: When it comes to data management, what are the greatest hurdles?
     
    CB: Integration across numerous sources and types of content is one of the greatest hurdles in data management today. It’s very difficult to define and construct a common format or structure that will accommodate all of the data that is relevant to a given task and relevant set of data silos. As a result, we need better, smarter approaches to deriving structured information form disparate content types and sources, irrespective of where those sources reside in an organization and what sorts of content they contain. 
     
    We’ve developed Vyasa Cortex to be able to connect to a wide range of data sources and to be able to send AI agents into these sources to identify relevant concepts, parameters associated with them and their relationships in a flexible, highly scalable manner.
     
    Contract Pharma: What are the biggest contributing factors that cause delays in R&D?
     
    CB: As is the case in many other industries, one key contributing factor is that delays in R&D can be caused by a wide range of inefficiencies in the constructive use of data to identify trends, patterns, interconnections and insights that would enable better decision making for value generation and path finding during project work.
     
    What is needed are systems capable of doing a better job of recognizing concepts, relationships and parameters in a wide range of content types (images, text, quantitative data) irrespective of formatting and type. We built Cortex to be able to connect to a wide range of data sources and be able to flexibly enable AI agents to crawl through the data in those sources creating a birds eye view of the information and interconnection available in those sources.  
     
    CP: What opportunities are available to drive cost reduction and greater efficiencies?
     
    CB: Deep learning/AI systems present a novel capability to identify patterns in data without the need for the definition of rule sets or heuristics. Essentially, we can train an AI agent on the identification of a wide range of what we call “concept types” in disparate data sources. 
     
    For example, things like genes, proteins or diseases in text, all the way to certain types of images or the objects in them can be defined as “concepts” in data. The more AI agents that we train to crawl through a given set of data sources, the more insights and efficiencies you can gain from those data sources.
     
    CP: What advances have been made leveraging analytics?
     
    CB: Nearly every organization today needs to reimagine itself as a data analytics company. The amount of digital data being generated on a moment-to-moment basis in the world means that there is an absolute wealth of information available to each business to leverage for efficiency gains, competitive advantage and enhanced decision making potential.
     
    At first, we will see these advantages come from the application of data analytics in a wide range of “low hanging fruit” scenarios where the value of novel deep learning/AI approaches can readily increase the capability of given workflows and processes across a wide range of vertically centered organizations from life sciences to healthcare to legal to fintech.
     
    I feel extremely lucky to be working at a time when we’ve been given this brand new tool (deep learning/AI) when we so desperately need it in order to more effectively utilize the wealth of data available to us across many sectors. Our mission at Vyasa is to enable a wide range of these capabilities for more effective leveraging of digital content through novel analytical approaches.


     

     
    Dr. Christopher Bouton, Vyasa’s founder and CEO, received his BA in Neuroscience from Amherst College in 1996 and his Ph.D. in Molecular Neurobiology from Johns Hopkins University in 2001. Previously Dr. Bouton was the CEO of Entagen a software company founded in 2008 that provided innovative Big Data products including Extera and TripleMap. Entagen's technologies won numerous awards including the "Innovative Technology of the Year Award for Big Data" from the Massachusetts Technology Leadership Council in 2012 and Entagen was recognized as a Gartner "Cool Vendor" in the Life Sciences in 2013. Entagen was acquired by Thomson Reuters in 2013. Dr. Bouton is an author on over a dozen scientific papers and book chapters and his work has been covered in a number of industry news articles.
    Related Searches
    • ceo
    • contract pharma
    • R&D
    • data analytics
    Suggested For You
    Legacy Pharma Solutions Legacy Pharma Solutions
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Regis Custom Pharma Regis Custom Pharma
    Adare Pharma Solutions Adare Pharma Solutions
    Celgene Enters AI Drug Discovery Deal with Exscientia Celgene Enters AI Drug Discovery Deal with Exscientia
    Ono Pharma, twoXAR Enter Drug Discovery Alliance Ono Pharma, twoXAR Enter Drug Discovery Alliance
    2019 Trends & Predictions 2019 Trends & Predictions
    Implementing AI in Drug Discovery Implementing AI in Drug Discovery
    Leveraging AI to Advance Discovery, Development and Delivery Leveraging AI to Advance Discovery, Development and Delivery
    AI in Pharma: Transforming Data into Drugs AI in Pharma: Transforming Data into Drugs
    Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery
    Cristers Selects Adents Prodigi Cloud Serialization Solution Cristers Selects Adents Prodigi Cloud Serialization Solution
    Merck KGaA, Cyclica in AI Screening Platform Pact Merck KGaA, Cyclica in AI Screening Platform Pact
    Three Ways Quality Can Impact a Business’s Bottom Line Three Ways Quality Can Impact a Business’s Bottom Line

    Related Online Exclusives

    • Clinical Trials | Information Technology
      The State of Clinical Trial Technology

      The State of Clinical Trial Technology

      Blake Adams of Florence discusses key report findings and the clinical trial software used to support Pfizer’s global COVID-19 vaccine study.
      Kristin Brooks, Contract Pharma 01.26.21

    • Clinical Trials | Drug Development | Information Technology
      Advancing Digital Endpoints in Clinical Trials

      Advancing Digital Endpoints in Clinical Trials

      An end-to-end approach to managing wearable devices through clinical development.
      Kristin Brooks, Contract Pharma 12.14.20

    • Drug Development | Information Technology
      Trade Secret Litigation: Vulnerabilities Within Pharma Amid Hacking Efforts

      Trade Secret Litigation: Vulnerabilities Within Pharma Amid Hacking Efforts

      Theft of IP belonging to companies developing biologics and other drugs, including COVID-19 treatments and vaccines, poses a threat to innovation.
      Kristin Brooks, Contract Pharma 08.19.20


    • Biologics, Proteins, Vaccines | Drug Discovery
      Cell Therapy for Solid Tumors

      Cell Therapy for Solid Tumors

      Is base editing the solution for solid tumor-based cell therapy?
      Jonathan Frampton, Corporate Development Partner, Horizon Discovery 06.26.20

    • Analytical Services | Biologics, Proteins, Vaccines | Drug Development | Drug Discovery | Laboratory Testing
      A Shifting Drug Development Landscape Amid COVID-19 Crisis

      A Shifting Drug Development Landscape Amid COVID-19 Crisis

      Responding to demand for challenging assays and custom solutions required for complex molecules, biologics, vaccines and other innovative therapies.
      Kristin Brooks, Contract Pharma 06.22.20

    • Drug Development | Information Technology
      Advancing AI Initiatives in R&D

      Advancing AI Initiatives in R&D

      Richard Lee of ACD/Labs discusses the possibilities of using AI in R&D, and what this outlook means for IT leaders at pharmaceutical organizations.
      Kristin Brooks, Contract Pharma 06.11.20


    • Clinical Trials | CRO News | Drug Development | Information Technology | R&D
      CRO Industry Update

      CRO Industry Update

      Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
      Kristin Brooks, Contract Pharma 04.27.20

    • Clinical Trials | Information Technology | QA/QC
      Managing Clinical Trials Amid the Coronavirus Pandemic

      Managing Clinical Trials Amid the Coronavirus Pandemic

      Patrick Hughes of CluePoints discusses the impact on clinical trials and how leveraging data may herald a long overdue paradigm shift in the industry.
      Kristin Brooks, Contract Pharma 04.06.20

    • cGMP Manufacture | Information Technology | Scale-up/Technology Transfer
      The Future of Pharmaceutical Manufacturing

      The Future of Pharmaceutical Manufacturing

      Neo PLM’s Cathal Strain discusses the need for a digital revolution to drive manufacturing innovation
      Kristin Brooks, Contract Pharma 02.12.20


    • Clinical Trials | CRO News | Drug Development | Industry News | Information Technology
      Janssen, PRA Design First Mobile Virtual Trial

      Janssen, PRA Design First Mobile Virtual Trial

      Kent Thoelke and Greg Licholai of PRA discuss the alliance, advances that have made virtual clinical trials possible, and the obstacles that remain
      Kristin Brooks, Contract Pharma 01.06.20

    • Clinical Trial Materials | Clinical Trials | Information Technology
      Contract Pharma’s 20th Anniversary Series: Clinical Supply

      Contract Pharma’s 20th Anniversary Series: Clinical Supply

      Technology plays a big role in clinical trials, supplies, and the rise of patient-centricity
      Kristin Brooks, Contract Pharma 10.29.19

    • Clinical Trials | CRO News | Drug Development | Information Technology | R&D
      Contract Pharma’s 20th Anniversary Series: CRO Perspective

      Contract Pharma’s 20th Anniversary Series: CRO Perspective

      Randy Marchbanks of PPD discusses how CRO operations have evolved to accommodate changing industry needs
      Kristin Brooks, Contract Pharma 10.28.19


    • Clinical Trials | Information Technology
      Clinical Trial Technology

      Clinical Trial Technology

      The use of new technology to monitor and manage clinical trials.
      Ricky Lakhani, Director of Product Management, PHARMASEAL 10.25.19

    • Clinical Trials | Drug Development | Information Technology
      Better Collaboration is Key to Speeding Trials

      Better Collaboration is Key to Speeding Trials

      Clinical leaders discuss bringing together disparate processes and systems for improved collaboration and more efficient trial execution at Veeva R&D Summit
      Jim Reilly, vice president of clinical strategy at Veeva Systems 10.18.19

    • Clinical Trials | Drug Development | Drug Discovery
      Highlights from ASCO

      Highlights from ASCO

      Recent treatment advances in multiple tumor types, research breakthroughs, and more
      Cristina Oliva, MD, Vice President and Head of Oncology Center of Excellence at IQVIA 06.11.19

    Trending
    • Pfizer Selects Seven Bridges To Support RNA Sequencing Data
    • Pfizer Partners With Medicines Manufacturing Innovation Center
    • Catalent Acquires Delphi Genetics
    • Charles River Acquires CDMO Cognate BioServices
    • Spark Therapeutics Appoints CTO
    Breaking News
    • Spark Therapeutics Appoints CTO
    • Cryoport Launches ESG Program
    • U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    • Thermo Fisher Scientific Completes Mesa Biotech Acquisition
    • Ashfield Engage, Popit Form Digital Monitoring Collaboration
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    GUM Recalls Oral Spray
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login